Literature DB >> 21878883

Transplantation: Does switching to a CNI-free regimen reduce cancer risk?

Rebecca Ireland.   

Abstract

Entities:  

Year:  2011        PMID： 21878883     DOI： 10.1038/nrneph.2011.123

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  2 in total

1.  Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.

Authors:  Josefina Alberú; Michael D Pascoe; Josep M Campistol; Francesco P Schena; Maria Del Carmen Rial; Martin Polinsky; John F Neylan; Joan Korth-Bradley; Robert Goldberg-Alberts; Eric S Maller
Journal:  Transplantation       Date:  2011-08-15       Impact factor: 4.939

Review 2.  Management of nonmelanoma skin cancer in 2007.

Authors:  Julie A Neville; Erin Welch; David J Leffell
Journal:  Nat Clin Pract Oncol       Date:  2007-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.